You have a type of ovarian cancer that’s fueled by estrogen. Your cancer has other specific molecular characteristics like biomarkers that are associated with good responses to aromatase inhibitors.

Ovarian cysts are very common in people who menstruate, with an estimated 10% to 30% of women — and potentially more — ...

Hormone replacement therapy (HRT) is a standard approach to menopause symptom management. However, some people have concerns about a potential link between HRT and ovarian cancer. While HRT can ...

Tamoxifen is hormone-modifying drug that doctors may prescribe to people with ovarian cancer. It blocks the activity of a hormone called estrogen. Learn more here.

Sometimes also called ovarian estrogen, the secretion of estrogen "begins around the time of puberty" and continues throughout reproductive life − "puberty to menopause," says Cynthia Stuenkel ...

Despite the fact that hormone therapy for menopausal symptoms has been approved in the U.S. since 1943, its influence on endometrial and ovarian cancer incidence and mortality remains unsettled ...

In 2024, an estimated 19,680 women in the United States will develop ovarian cancer. About 12,740 deaths will occur due to the disease. The five-year survival rate for ovarian cancer is typically ...

For patients with ovarian and endometrial cancer, receiving conjugated equine estrogen (CEE; a drug that includes estrogen hormones to treat menopause symptoms) alone was associated with significantly ...

Hormone therapy (also called hormonal therapy or endocrine therapy) slows or stops the growth of hormone-sensitive tumors by blocking the body’s ability to produce hormones or by interfering ...